Randomized, Multicenter, Open-label, Phase III Study of Plitidepsin in Combination With Dexamethasone vs. Dexamethasone Alone in Patients With Relapsed/Refractory Multiple Myeloma
Phase of Trial: Phase III
Latest Information Update: 04 Oct 2017
At a glance
- Drugs Plitidepsin (Primary) ; Dexamethasone
- Indications Multiple myeloma
- Focus Registrational; Therapeutic Use
- Acronyms ADMYRE
- Sponsors PharmaMar
- 04 Oct 2017 According to a PharmaMar media release, the company has submitted a Marketing Authorisation Application to the Swiss Agency for Therapeutic Products (Swissmedic) for Aplidin for the treatment of patients with multiple myeloma.
- 21 Sep 2017 Planned End Date changed from 1 may 2017 to 1 Nov 2017.
- 21 Sep 2017 Planned primary completion date changed from 1 may 2017 to 1 nov 2017.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History